Total Payments
$299.32
2020 Payments
$145.97
Companies
10
Transactions
18
Medicare Patients
239
Medicare Billing
$74,773

Payment Breakdown by Category

Food & Beverage$299.32 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $299.32 18 100.0%

Top Paying Companies

Company Total Records Latest Year
Allergan, Inc. $111.12 7 $0 (2020)
Vanda Pharmaceuticals Inc. $37.62 2 $0 (2019)
Neos Therapeutics, LP $36.65 2 $0 (2020)
Ironshore Pharmaceuticals Inc. $19.17 1 $0 (2020)
Lundbeck LLC $18.85 1 $0 (2020)
Otsuka America Pharmaceutical, Inc. $18.63 1 $0 (2019)
Adlon Therapeutics L.P. $16.07 1 $0 (2020)
Shire North American Group Inc $14.70 1 $0 (2019)
Takeda Pharmaceuticals U.S.A., Inc. $14.68 1 $0 (2020)
Teva Pharmaceuticals USA, Inc. $11.83 1 $0 (2020)

Payment History by Year

Year Amount Transactions Top Company
2020 $145.97 9 Allergan, Inc. ($49.12)
2019 $153.35 9 Allergan Inc. ($62.00)

All Payment Transactions

18 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
03/10/2020 Neos Therapeutics, LP Adzenys XR-ODT (Drug), Cotempla XR-ODT Food and Beverage In-kind items and services $16.25 General
Category: ADHD
03/09/2020 Ironshore Pharmaceuticals Inc. JORNAY PM (Drug) Food and Beverage In-kind items and services $19.17 General
Category: Central Nervous Stimulant ADHD
03/07/2020 Allergan, Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $14.20 General
Category: NEUROSCIENCE
03/05/2020 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $18.85 General
Category: PSYCHIATRY
02/12/2020 Takeda Pharmaceuticals U.S.A., Inc. VYVANSE (Drug) Food and Beverage In-kind items and services $14.68 General
Category: NEUROSCIENCE
02/05/2020 Allergan, Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $12.64 General
Category: NEUROSCIENCE
01/17/2020 Teva Pharmaceuticals USA, Inc. AUSTEDO (Drug) Food and Beverage In-kind items and services $11.83 General
Category: Central Nervous System
01/15/2020 Allergan, Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $22.28 General
Category: NEUROSCIENCE
01/12/2020 Adlon Therapeutics L.P. ADHANSIA XR (Drug) Food and Beverage Cash or cash equivalent $16.07 General
Category: PRESCRIPTION STIMULANT
11/22/2019 Neos Therapeutics, LP Adzenys XR-ODT (Drug), Cotempla XR-ODT Food and Beverage In-kind items and services $20.40 General
Category: ADHD
11/07/2019 Allergan Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $15.90 General
Category: NEUROSCIENCE
11/06/2019 Shire North American Group Inc VYVANSE (Drug) Food and Beverage In-kind items and services $14.70 General
Category: NEUROSCIENCE
11/05/2019 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $18.63 General
Category: PSYCHIATRY
11/01/2019 Vanda Pharmaceuticals Inc. Fanapt (Drug), Hetlioz Food and Beverage In-kind items and services $24.47 General
Category: Schizophrenia
10/16/2019 Allergan Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $11.33 General
Category: NEUROSCIENCE
10/01/2019 Allergan Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $14.77 General
Category: NEUROSCIENCE
09/27/2019 Vanda Pharmaceuticals Inc. Fanapt (Drug), Hetlioz Food and Beverage In-kind items and services $13.15 General
Category: Schizophrenia
09/04/2019 Allergan Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $20.00 General
Category: NEUROSCIENCE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 67 278 $74,444 $22,065
2022 2 46 177 $41,033 $12,057
2021 2 44 186 $46,753 $15,848
2020 3 82 327 $64,100 $24,803
Total Patients
239
Total Services
968
Medicare Billing
$74,773
Procedure Codes
10

All Medicare Procedures & Services

10 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 38 186 $55,682 $16,751 30.1%
90833 Psychotherapy with evaluation and management visit, 30 minutes Office 2023 16 53 $10,113 $2,802 27.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 13 39 $8,649 $2,512 29.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 32 136 $33,881 $10,109 29.8%
90833 Psychotherapy with evaluation and management visit, 30 minutes Office 2022 14 41 $7,152 $1,948 27.2%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 31 145 $38,282 $13,620 35.6%
90833 Psychotherapy performed with evaluation and management visit, 30 minutes Office 2021 13 41 $8,471 $2,228 26.3%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 34 185 $37,000 $15,561 42.1%
90833 Psychotherapy, 30 minutes Office 2020 30 124 $21,700 $7,171 33.0%
90792 Psychiatric diagnostic evaluation with medical services Office 2020 18 18 $5,400 $2,071 38.4%

About David Appel

David Appel is a Student in an Organized Health Care Education/Training Program healthcare provider based in Burlington, Vermont. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/26/2015. The National Provider Identifier (NPI) number assigned to this provider is 1235523325.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Appel has received a total of $299.32 in payments from pharmaceutical and medical device companies, with $145.97 received in 2020. These payments were reported across 18 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($299.32).

As a Medicare-enrolled provider, Appel has provided services to 239 Medicare beneficiaries, totaling 968 services with total Medicare billing of $74,773. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.

Practice Information

Products in Payments

  • VRAYLAR (Drug) $111.12
  • Fanapt (Drug) $37.62
  • REXULTI (Drug) $37.48
  • Adzenys XR-ODT (Drug) $36.65
  • VYVANSE (Drug) $29.38
  • JORNAY PM (Drug) $19.17
  • ADHANSIA XR (Drug) $16.07
  • AUSTEDO (Drug) $11.83

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Burlington